Diagnostics and therapeutics for glaucoma

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S004000, C435S029000

Reexamination Certificate

active

07807355

ABSTRACT:
Methods and compositions for diagnosing and treating glaucoma are disclosed.

REFERENCES:
patent: 5798380 (1998-08-01), Kaufman et al.
patent: 5885776 (1999-03-01), Stone et al.
patent: 5916778 (1999-06-01), Stone et al.
patent: 5925748 (1999-07-01), Stone et al.
patent: 5928662 (1999-07-01), Phillips
patent: 6150161 (2000-11-01), Nguyen et al.
patent: 6441053 (2002-08-01), Klein et al.
patent: 0 879 885 (1998-11-01), None
patent: 0 943 684 (1999-09-01), None
patent: WO 98/24932 (1998-06-01), None
patent: WO 98/42296 (1998-10-01), None
patent: WO 98/44108 (1998-10-01), None
patent: WO 98/54325 (1998-12-01), None
patent: WO 99/09152 (1999-02-01), None
patent: WO 99/42481 (1999-08-01), None
patent: WO 00/07565 (2000-02-01), None
patent: WO 01/19855 (2000-09-01), None
Rezaie et al. 2002. Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin. Science. 295: 1077-1079.
Moon et al. 2002. The Promise and Perils of Wnt Signaling Through b-Catenin. Science 296:1644-1646.
Steele et al. 2006. Microarray Analysis of Retinal Gene Expression in the DBA/2J Model of Glaucoma. Invest Ophthalmol Vis Sci. 47:977-985.
Chang et al. 1999. Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium. Hum Mol Genet. Apr;8(4):575-83.
Seeber. 2009. While not preventable, glaucoma is treatable. http://www.woodwardnews.net/homepage/local—story—018090622.html/resources—printstory. p. 1-2.
Kohn et al. Wnt and calcium signaling: beta-Catenin-independent pathways. Cell Calcium 38 (2005) 439-446.
Klein et al. 2005. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 89:284-287.
Encyclopedia—Ocular Hypertension. 2010. downloaded from http://www.visionrx.com/Library/enc/enc—ocular.asp. p. 1-2.
Craig et al.; “Glaucoma Genetics: Where are we? Where will we go?”, Current Opinion in Ophthalmology 10: 126-134, (1999.
International Search Report Completed on Jun. 13, 2002 and Mailed on Jun. 26, 2002.
Zhou et al. (1998),Up-Regulation of Human Secreted Frizzled Homolog in Apoptosis and its Down-Regulation in Breast Tumors, Int. J. Cancer 78:95.
Dale (1998),Signal Transduction by the Wnt Family of Ligands, Biochem. J. 329:209.
Brown et al. (1998),Wnt Signaling: Why is Everything so Negative?. Curr. Opin. in Cell Biol. 10:182.
Clark et al. (1995),Cytoskeletal Chages in Cultured Human Glaucoma Trabecular Meshwork Cells, J. Glaucoma 4:183.
Wilson et al. (1993),Dexamethasone Induced Ultrastructural Changes in Cultured Human Trabecular Meshwork Cells, Curr. Eye Res. 12:783.
Clark et al. (1996),Inhibition of Dexamethasone-Induced Cytoskeletal Changes in Cultural Human Trabecular Meshwork Cells by Tetralryclrocortisol, Invest. Ophthal. & Visual Science 37(5):805.
Wordinger et al. (1998),Cultured Human Trabecular Meshwork Cells Express Functional Growth Factor Receptors, Invest. Ophthal. & Visual Science 39(9):1575.
Steely et al. (2000),The Similarity of Protein Expression in Trabecular Meshwork and Lamina Cribrosa: Implications for Glaucoma, Exp. Eye Res. 70:17.
Wilder et al. (1995),Dual Functions of Wingless in the Drosophila Leg Imaginal Disc, Development 121:477.
Dennis et al. (1999),A Secreted Frizzled Related Protein, FrzA. Selectively Associates with Wnt-1 Protein and Regulates Wnt-1 Signaling, J. Cell Sci. 112:3815.
Chang et al. (1999),Cloning and Characterization of a Secreted Frizzled-Related Protein That is Expressed by the Retinal Pigment Epithelium, Human Molcular Genetics 8(4):575.
Jasoni et al. (1999),Analysis of Chicken Wnt-13 Expression Demonstrates Coincidence with Cell Division in the Developing Eye and is Consistent with a Role in Induction, Develop. Dynamics 215:215.
Deardorff et al. (1999),Xenopus Frizzled-2 is Expressed Highly in the Developing Eye, Otic Vesicle and Somites, Mechanisms of Development 87:229.
Trevor C. Dale, Biochem. J. (1998) pp. 209-229.
Randall T. Moon et al., Science, May 31, 2002, vol. 296, pp. 1644-1646.
Tayebeh Rezaie et al., Science, Feb. 8, 2002, vol. 295, pp. 1077-1079.
Huelsken, J., et al., “New Aspects of Wnt Signaling Pathways in Higher Vertebrates,” Current Opinion in Genetics & Development, 2001, vol. 11, No. 5, pp. 547-553.
Office Action issued by European Patent Office in corresponding European Application No. 01 913 057.4-1222 dated Aug. 5, 2005.
Miller, et al., “Mechanism and Function of Signal Transduction by the Wnt/β-Catenin and. Wnt/Ca2+Pathways,” Oncogene, vol. 18, Dec. 20, 1999, pp. 7860-7872.
Nusse, “Model of Wnt Signaling,” Jul. 2005, retrieved from Internet URL:http://www.stanford.edu/˜rnusse/pathways/cell2-html.
“Wnt Complex,” Jul. 2005, retrieved from Internet: URL:http://www.em2.molmed.uni-erlangen.de/pics/Wnt—complex—highQ/jpg>.
European Search Report issued in corresponding European Patent Application No. 08157330.5 dated Nov. 17, 2008 (7 pages).
Bowie, et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,” Science, New Series, vol. 247, No. 4948, Mar. 16, 1990, pp. 1306-1310 (6 pages).
Burgess et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue,” The Journal of Cell Biology, vol. 111, Nov. 1990, pp. 2129-2138 (10 pages).
Pawson et al., “Assembly of Cell Regulatory Systems Through Protein Interaction Domains,” Science, vol. 300, Apr. 18, 2003, pp. 445-452 (8 pages).
Office Action from the U.S. Patent and Trademark Office issued in corresponding U.S. Appl. No. 12/420,865 dated Jul. 26, 2010 (29 pages).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostics and therapeutics for glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostics and therapeutics for glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostics and therapeutics for glaucoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4241550

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.